Short-Term Fasting Synergizes with Solid Cancer Therapy by Boosting Antitumor Immunity
Short-term fasting (STF), using a low caloric, low protein fasting mimicking diet (FMD), appears to be a promising strategy to enhance chemotherapy-based cancer efficacy, while potentially alleviating toxicity. Preclinical results suggest that enhanced tumor immunity and decreased growth signaling,...
Main Authors: | Nadia de Gruil, Hanno Pijl, Sjoerd H. van der Burg, Judith R. Kroep |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/6/1390 |
Similar Items
-
IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial)
by: Nadia de Gruil, et al.
Published: (2023-12-01) -
How Far Are We from Prescribing Fasting as Anticancer Medicine?
by: Maria V. Deligiorgi, et al.
Published: (2020-12-01) -
Effect of fasting mimicking diet on cardiovascular risk factors
by: Jakub Kasprowicz, et al.
Published: (2023-01-01) -
Fasting-Mimicking Diet Inhibits Autophagy and Synergizes with Chemotherapy to Promote T-Cell-Dependent Leukemia-Free Survival
by: Roberta Buono, et al.
Published: (2023-12-01) -
Fasting: From Physiology to Pathology
by: Dongmei Tang, et al.
Published: (2023-03-01)